Lineage Cell Therapeutics, Inc. Share Price
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.255 USD | +4.58% |
|
+0.41% | -26.05% |
| 05-13 | Lineage Cell Therapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-12 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 299M 258M 237M 223M 419M 28.28B 423M 2.81B 1.09B 13.85B 1.12B 1.1B 48B | P/E 2026 * |
-17.1x | P/E 2027 * | -13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 258M 237M 223M 419M 28.28B 423M 2.81B 1.09B 13.85B 1.12B 1.1B 48B | EV / Sales 2026 * |
16.7x | EV / Sales 2027 * | 16.5x |
| Free-Float |
95.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | -2.44% | ||
| 1 week | -1.64% | ||
| Current month | -9.77% | ||
| 1 month | -4.00% | ||
| 3 months | -25.00% | ||
| 6 months | -33.33% | ||
| Current year | -28.14% |
| 1 week | 1.2 |  | 1.32 |
| 1 month | 1.18 | | 1.36 |
| Current year | 1.18 | | 1.98 |
| 1 year | 0.83 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 3 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 16/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 13/11/2022 |
| Chief Operating Officer | - | 30/11/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 30/06/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 10/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 26/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-11 | Buy | Chief Executive Officer | 15,000 | 0.0065% | ||
| 03-04 | Free | Chief Financial Officer | 1,050,000 | 0.4559% | ||
| 03-04 | Free | Chief Executive Officer | 3,250,000 | 1.4110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.44% | -1.64% | +38.76% | -14.89% | 299M | |
| -0.66% | -1.44% | -12.15% | -10.42% | 43.51B | |
| -2.17% | +4.70% | +293.71% | +535.99% | 33.29B | |
| -1.60% | -1.58% | -0.19% | +31.82% | 29.34B | |
| +0.44% | -3.80% | +12.51% | -17.06% | 29.9B | |
| -0.29% | +2.65% | +13.24% | +21.04% | 25.42B | |
| +3.54% | +8.43% | - | - | 14.36B | |
| -1.26% | -1.11% | +53.37% | +108.10% | 13.18B | |
| -1.53% | -5.47% | +1.98% | +3.07% | 12.72B | |
| -1.18% | -2.00% | +107.41% | +78.18% | 12.08B | |
| Average | -0.45% | +0.36% | +56.52% | +81.76% | 21.41B | |
| Weighted average by Cap. | -0.26% | +0.63% | +60.03% | +103.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.94M 15.46M 14.23M 13.36M 25.09M 1.7B 25.36M 168M 65.53M 830M 67.32M 65.89M 2.88B | 18.09M 15.59M 14.36M 13.48M 25.31M 1.71B 25.58M 170M 66.1M 838M 67.9M 66.46M 2.9B |
| Net income | -23.79M -20.5M -18.88M -17.72M -33.28M -2.25B -33.63M -223M -86.9M -1.1B -89.27M -87.38M -3.82B | -31.66M -27.28M -25.12M -23.59M -44.29M -2.99B -44.76M -297M -116M -1.47B -119M -116M -5.08B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 1.235 $ | +2.92% | 24,621 |
| 16/06/26 | 1.200 $ | -2.44% | 1,649,593 |
| 15/06/26 | 1.230 $ | -3.15% | 1,318,703 |
| 12/06/26 | 1.270 $ | -0.78% | 1,018,884 |
| 11/06/26 | 1.280 $ | +4.07% | 908,726 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
